Meeting the threat of both common and rare infections that continue to develop resistance over time is a race between drug development and bacterial evolution.
To believe that is to believe that the arc of human evolution suddenly jumped the curve in the 1980s, producing a race of 300-pound men able to leap tall buildings and run the 40-yard dash like a bullet.